GaviLyte-H and Bisacodyl (GAVIS Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the GaviLyte-H and Bisacodyl drug offered from GAVIS Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GAVIS Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-04-21 |
| END MARKETING DATE: | 0000-00-00 |
GaviLyte-H and Bisacodyl HUMAN PRESCRIPTION DRUG Details:
| Item Description | GaviLyte-H and Bisacodyl from GAVIS Pharmaceuticals, LLC |
| LABELER NAME: | GAVIS Pharmaceuticals, LLC |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2015-04-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43386-071_78f1f6cb-09bd-4c5c-ba86-bfbd66e9576b |
| PRODUCT NDC: | 43386-071 |
| APPLICATION NUMBER: | ANDA202217 |